Enalaprilat
Back to searchMolecule Structure
Scientific Name
Enalaprilat
Description of the Drug
Enalaprilat is an antihypertensive agent used for the management of hypertension when oral therapy is not practical.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09477
http://www.drugbank.ca/drugs/DB09477
Brand Name(s)
Vasotec
Company Owner(s)
Chartwell Injectables Llc, Biovail Laboratories International Srl, Hospira Inc, Hikma Farmaceutica (Portugal) Sa, Dr Reddys Laboratories Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Angiotensin-converting enzyme | SINGLE PROTEIN | INHIBITOR | CHEMBL1808 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL37289 | |
| Human Metabolome Database | HMDB0041886 | |
| DrugBank | DB09477 | |
| PubChem: Thomson Pharma | 14900718 | 14876097 |
| PubChem | 5462501 | |
| Mcule | MCULE-3507396113 | |
| LINCS | LSM-6026 | |
| Nikkaji | J21.388H | |
| PDBe | EAL | |
| BindingDB | 50367254 | |
| EPA CompTox Dashboard | DTXSID0048975 | |
| DrugCentral | 1006 | |
| Brenda | 100957 | 30808 |
| ChemicalBook | CB3163049 | |
| Guide to Pharmacology | 6332 | |
| rxnorm | ENALAPRILAT ANHYDROUS | ENALAPRILAT |
| KEGG Ligand | C11720 | |
| ChEBI | 4786 | |
| ZINC | ZINC000003812851 |
